A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Autolus Therapeutics plc ADR’s current trading price is -47.20% away from its 52-week high, while its distance from the 52-week low is 138.91%. The stock’s price range for this time frame has been between $1.11 and $5.00. The trading volume of the company’s shares in the Healthcare reached around 2.86 million for the day, which was evidently higher than the average daily volume of 2.14 million over the last three months.
The current stock price for Autolus Therapeutics plc ADR (AUTL) is $2.64. The stock experienced a significant increase during the last trading session, reaching $13.0 after opening at $2.64. It dipped to a low of $5.8 before ultimately closing at $2.68.
In terms of market performance, Autolus Therapeutics plc ADR had a somewhat regular. The highest value for the stock in the past year was $5.00 on 10/18/24, while the lowest value was $1.11 on 04/11/25.
How Financial Performance Impacts Market Capitalization
Autolus Therapeutics plc ADR (AUTL) has experienced a quarterly rise of 74.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 702.61M and boasts a workforce of 647 employees.
Decoding Analysts’ Ratings for Autolus Therapeutics plc ADR
As of right now, 9 analysts are rating Autolus Therapeutics plc ADR as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.82, with a change in price of +0.91. Similarly, Autolus Therapeutics plc ADR recorded 1,986,929 in trading volume during the last 100 days, posting a change of +52.60%.
How AUTL’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AUTL stands at 0.84. Similarly, the long-term debt-to-equity ratio is also 0.83.
AUTL Stock Stochastic Average
The raw stochastic average for Autolus Therapeutics plc ADR over the last 50 days is presently at 96.04%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 88.12%. Further, the company’s Stochastic %K and %D values for the last 20 days were 89.60% and 79.73%, respectively.
AUTL Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -38.60% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 22.22%. Over the past 30 days, the price of AUTL has fallen by 16.30%. And in the last five days, it has surged by 9.09%.
